Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011909

« Back to Dashboard

NDA 011909 describes NARDIL, which is a drug marketed by Parke Davis and is included in one NDA. It is available from one supplier. Additional details are available on the NARDIL profile page.

The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.
Summary for 011909
Applicant:Parke Davis
Ingredient:phenelzine sulfate
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Pharmacology for NDA: 011909
Mechanism of ActionMonoamine Oxidase Inhibitors
Medical Subject Heading (MeSH) Categories for 011909
Suppliers and Packaging for NDA: 011909
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NARDIL phenelzine sulfate TABLET;ORAL 011909 NDA Parke-Davis Div of Pfizer Inc 0071-0350 N 0071-0350-60

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.